Tybriva 140 mg Capsule
$118.99
$92.81
Tybriva 140 mg capsule is a targeted anti-cancer treatment designed to combat specific blood cancers, including mantle cell lymphoma (MCL), chronic lymphocytic leukaemia (CLL), and Waldenström's macroglobulinemia (WM). Its active ingredient functions by inhibiting the activity of protein kinases, which play a crucial role in the growth and survival of cancer cells. This innovative mechanism helps slow down or stop the progression of these malignancies, providing hope for patients facing challenging diagnoses. It is essential for patients to discuss their full medical history with their healthcare provider before starting Tybriva, as there are important warnings related to potential side effects and interactions with other medications. Regular monitoring during treatment is recommended to ensure optimal results and manage any adverse effects effectively. With Tybriva, patients have access to a vital option in the fight against certain blood cancers, paving the way for improved outcomes and quality of life. Always consult your healthcare professional to determine if Tybriva is the right choice for your specific condition.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Tybriva 140 mg capsule is primarily used in the treatment of chronic lymphocytic leukemia (CLL). This type of cancer affects the blood and bone marrow, leading to an accumulation of abnormal lymphocytes. By targeting these malignant cells, Tybriva helps to manage the disease and improve overall patient outcomes. It is commonly prescribed for patients who require effective management of their CLL symptoms.
• Another indication for Tybriva 140 mg capsule is mantle cell leukemia. This aggressive form of non-Hodgkin lymphoma can be challenging to treat, but Tybriva offers a therapeutic option that can help control the proliferation of cancerous cells. Patients receiving Tybriva often experience a reduction in tumor burden, which can lead to improved quality of life. The medication is integrated into treatment regimens tailored to individual patient needs.
• Tybriva 140 mg capsule is also utilized in managing Waldenström's macroglobulinemia, a rare type of lymphoma characterized by high levels of a specific protein in the blood. By administering Tybriva, healthcare providers aim to decrease the abnormal protein levels and alleviate symptoms associated with this condition. This treatment option is essential for patients seeking to maintain their health and manage the impact of the disease. Tybriva plays a critical role in the therapeutic landscape for those affected by this complex disorder.
Benefits
Tybriva 140 mg Capsule helps in treating blood cancer in patients who were not able to recover from previous medications. It helps to prevent the cancer cells to grow and multiply.
Side Effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:
Most Common Side Effects
• Swollen feet and ankle
• Body pain Blurred Vision
• Vomiting
• Nausea
• Pneumonia
• Bloody Urine
• Constipation
• Breathlessness
• Bruises and Rashes
• Tiredness
• Numbness and Weakness
• Mouth Sores
Common Side Effects
• Low Count of Blood Cells
• High Blood Pressure
• Tumor Lysis Syndrome
• Allergic Reactions
• Infections
• Heart Problems
How To Use
Tybriva 140 mg Capsule can be taken without or with food, as advised by your doctor. You must follow every guideline of your doctor strictly to get the best results.
Safety Advice
Not Found